Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.

Gang LiAlexander KeenanMehmet DaskiranMaju MathewsIsaac NuamahCamille OrmanKruti JoshiArun SinghAnnabelle GodetKatalin Pungor Srihari Gopal

Published in: Patient preference and adherence (2021)

Risk of relapse was significantly lower, and treatment adherence was significantly higher in PP3M cohort compared with PP1M cohort. Higher treatment adherence was associated with lower relapse rate.

Keyphrases

public health
healthcare
type diabetes
risk assessment
insulin resistance
human health
adverse drug
data analysis